AzTrials
AzTrials

Severe MalnutritionNCT02413905

Characterizing the Gut Microbiota Alteration Associated With Severe Acute Malnutrition

An observational study of Severe Malnutrition and Malnutrition, run by Institut Hospitalo-Universitaire Méditerranée Infection at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

The investigators performed two case-control studies in Niger and Senegal analysing fecal microbiota to characterize the specificity of the gut microbiota alteration associated with severe acute malnutrition (SAM). Read more about this study

Who is it for?
Ages Up to 59 monthsHealthy volunteers can take part
What is being tested?
Stool samples
How many people
100 participants
Where
2 sitesin 2 countries
Study dates
Jan 2014to Mar 2015
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 59 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Children from Niamey and Dakar, Senegal

Who may be able to join

  • Children aged 0-59 months of varying nutritional status from Niamey (Niger) and Dakar (Senegal).

Who cannot join

  • Absence of parent or patient consent, antibiotic administration <2 months before stool collection and insufficient fecal amount. Exclusion criteria for controls included any form of malnutrition, presence of fever, acute respiratory infection (cough), acute or chronic diarrhea in the previous 4 weeks. Symptoms and complications of malnutrition (cough, fever, diarrhoea, vomiting) nor other form of malnutrition (moderate to severe stunting and underweight) were not a reason of exclusion for cases since they are considered as direct consequence and part of severe acute malnutrition.

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Niger1 site
  • Hopital National

    Niamey

Other trials in Niger

Senegal1 site
  • Clinic Notre Dame de L'Esperance, Thiaroye

    Dakar

Other trials in Senegal

About this study

The investigators performed two case-control studies in Niger and Senegal analysing fecal microbiota to characterize the specificity of the gut microbiota alteration associated with severe acute malnutrition (SAM).

Read the detailed description

Fecal samples of cases (severe acute malnutrition (SAM) ascertained according to the WHO definition) and controls (asymptomatic healthy children ascertained by clinical and anthropometric criteria) were analysed by v3v4 16S rRNA sequencing, redox and pH measurement and using specific polymerase chain reaction targeting Methanobrevibacter smithii and Bacteroides thetaiotaomicron. Based on the literature and oxydative stress reported in SAM, the investigators tested if the proportion of aerotolerant prokaryotes is increased among gut prokaryotes enriched in SAM in comparison to prokaryotes enriched in controls. The investigators further linked this to fecal redox potential and assessed the total number of bacteria in feces by flux cytometry.

Being tested
Stool samples
Medical subject headings
Malnutrition, Infant Nutrition Disorders, Child Nutrition Disorders, Kwashiorkor, Protein-Energy Malnutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Stool samplesBiological

    Stool samples

Study groups in NCT02413905
Study groupRoleWhat they receive
SenegalStool samples on Children with and without severe acute malnutrition in Senegal recruited in 3 locations (Dakar, Dielmo and Ndiop)
Receives: Biological: Stool samples
NigerStool samples Children with and without severe acute malnutrition in Niger recruited in Niamey
Receives: Biological: Stool samples

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Aerotolerant Odds ratio (AOR)

    AOR = (number of aerotolerant prokaryotes enriched in the gut of children with SAM * number of obligate anaerobic prokaryotes enriched in controls)/(number of aerotolerant prokaryotes enriched in controls * number of obligate anaerobic prokaryotes enriched in children with SAM)

    Measured: 1 day (Participants were not followed as this is a case-contol study only clinical and anthropometric data and fecal samples were collected the day of inclusion)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2015 (estimated)
  2. Study startJan 2014
  3. Primary completionMar 2015
  4. Study completionMar 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02413905
Sponsor's protocol ID
SAMGUT
Status last verified
Apr 2015
First submitted
30 Mar 2015
Last updated
10 Apr 2015
Results posted
No
Data monitoring committee
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in